The new indication could give Novo Nordisk a boost against rivals in the GLP-1 agonist class, including Eli Lilly, whose dual GIP/GLP-1 agonist Mounjaro (tirzepatide) competes in the diabetes category and is in a phase 3 trial (TREASURE-CKD) looking at a CKD indication in people with obesity, with and without diabetes
However, emerging studies have shown that DAMPs that originate from neighbouring cells, and even from distal tissues or organs, also mediate sterile inflammatory responses
Ex-4 exerts regulatory control over the PI 3 K/Akt/Foxo1 pathway, impeding the nuclear entry of Foxo1 and consequently enhancing the expression of insulin gene transcription factors PDX-1 and MafA
J.MitchellJ
*Store lyophilized peptide at 20 C in a dry, dark location *Avoid repeated freezethaw cycles *Protect from prolonged exposure to light Description BPC-157 (Body Protection Compound-157) is a synthetic peptide consisting of 15 amino acids and is supplied as a lyophilized peptide powder for laboratory research and analytical applications
Peptide legality and FDA approval varies and needs to be checked by your doctor